Sponsor Pipeline

Biogenea Pharmaceuticals Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
5
Disease Areas
Active Trials by Phase
Early Phase 1
4
Active Trials
NCT IDTitleConditionStatus
Early Phase 1
NCT07077616 Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM… Glioma Recruiting
NCT07328087 COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III… Colorectal Cancer Metastatic Recruiting
NCT07285434 Clinical Study of the Therapeutic Effectiveness of In-silico-Designed, Machine Learning… NSCLC (Non-small Cell Lung Cancer) Enrolling by Invitation
NCT07316361 GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk… Endometrial Carcinoma Enrolling by Invitation
Disease Areas
Get alerts when Biogenea Pharmaceuticals Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free